New Full-Body PET scanner promises faster scans, less radiation
NCT ID NCT07263815
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study compares a new total body PET scanner (Omni TB) with conventional PET in 25 adult cancer patients. The new scanner can image the whole body at once with higher sensitivity, potentially allowing shorter scan times and lower radiation doses. Researchers will assess whether image quality is as good or better than current scanners.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PET/CT scanner (GE Omni Total Body 128cms)
What this could lead to
If successful, this scanner could allow faster, lower-radiation PET scans without losing image quality, improving patient comfort and safety.
What could go wrong
This is a small, early-stage imaging study (25 participants) focused on feasibility, not treatment. The new scanner may not prove superior in routine clinical use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia